• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·S. Africa·Healthcare·ACT.JO
Share

AfroCentric Investment Corporation Limited Stocks

ZAC 70Last Updated 13.10.2026

Issuer Rating

4/7
Performance

Strong

Risk

High

Recommendation

Hold

Market Cap

ZAC 361015.54461

ZAC 70
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

AfroCentric Investment Corporation Limited, an investment holding firm established in 2008 and headquartered in Roodepoort, South Africa, focuses on providing comprehensive health administration and risk management solutions to the healthcare industry. The company operates through several key segments: Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology. Its diverse service portfolio includes supplying documentation-based care equipment and administrative support to 12 musculoskeletal treatment centers. Additionally, AfroCentric manages the retail and wholesale distribution of pharmaceutical products through brands such as Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health. The corporation also offers vital management solutions for HIV and other health conditions. Its geographical reach extends across South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is underpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 14:43

Morning in New York: Moderate Inflation Will Give the Fed Some Breathing Room and Open the Door for a Rally

14.10.2026 13:31

A key supplier of machines for manufacturing AI chips can't keep up with demand. What about the stock?

14.10.2026 12:41

"All the Money in the World": Nebius's Competitor Aims to Attract Insurers' Capital for AI

14.10.2026 11:28

Retail Investors Have Returned to Betting on AI Amid a Downturn in the Chip Industry — Citadel

14.10.2026 10:34

Top Stories This Morning: Anthropic Warns of a New Threat; Luxury Market Loses $350 Billion

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026